Europium-doped amorphous calcium phosphate porous nanospheres: preparation and application as luminescent drug carriers

Calcium phosphate is the most important inorganic constituent of biological tissues, and synthetic calcium phosphate has been widely used as biomaterials. In this study, a facile method has been developed for the fabrication of amorphous calcium phosphate (ACP)/polylactide-block-monomethoxy(polyethyleneglycol) hybrid nanoparticles and ACP porous nanospheres. Europium-doping is performed to enable photoluminescence (PL) function of ACP porous nanospheres. A high specific surface area of the europium-doped ACP (Eu(3+):ACP) porous nanospheres is achieved (126.7 m(2)/g). PL properties of Eu(3+):ACP porous nanospheres are investigated, and the most intense peak at 612 nm is observed at 5 mol% Eu(3+ )doping. In vitro cytotoxicity experiments indicate that the as-prepared Eu(3+):ACP porous nanospheres are biocompatible. In vitro drug release experiments indicate that the ibuprofen-loaded Eu(3+):ACP porous nanospheres show a slow and sustained drug release in simulated body fluid. We have found that the cumulative amount of released drug has a linear relationship with the natural logarithm of release time (ln(t)). The Eu(3+):ACP porous nanospheres are bioactive, and can transform to hydroxyapatite during drug release. The PL properties of drug-loaded nanocarriers before and after drug release are also investigated.